A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes
Clinical trial NCT02964104 · COMPLETED
Trial details
- NCT number
- NCT02964104
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2017-12-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.